FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Lewis

Research Profile

Living Beings

Anatomy

Physiology

Phenotype

Disorders

Chemicals & Drugs

Procedures

Phenomena

Drug Contamination

Co-author Network

Publications

TOP 3
Belete Teferedegne; Keith W C Peden; Andrew M Lewis; Haruhiko Murata
Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCR.
Romelda L Omeir; Keith W C Peden; Philip J Snoy; Belete Teferedegne; Joel J Beren; Lauren R Brinster; James L Cook; Gideon S Foseh; Andrew M Lewis
Heterogeneity of the tumorigenic phenotype expressed by Madin-Darby canine kidney cells.
Haruhiko Murata; Juliete Macauley; Andrew M Lewis; Keith Peden
Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Lewis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Belete Teferedegne; Keith W C Peden; Andrew M Lewis; Haruhiko Murata
Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCR.
PloS one 2013;8(2):e56023.
2011: Romelda L Omeir; Keith W C Peden; Philip J Snoy; Belete Teferedegne; Joel J Beren; Lauren R Brinster; James L Cook; Gideon S Foseh; Andrew M Lewis
Heterogeneity of the tumorigenic phenotype expressed by Madin-Darby canine kidney cells.
Comparative medicine 2011;61(3):243-50.
2011: Haruhiko Murata; Juliete Macauley; Andrew M Lewis; Keith Peden
Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds.
Vaccine 2011;29(17):3155-61.
2010: Belete Teferedegne; Haruhiko Murata; Mariam Quiñones; Keith W C Peden; Andrew M Lewis
Patterns of microRNA expression in non-human primate cells correlate with neoplastic development in vitro.
PloS one 2010;5(12):e14416.
2010: Li Sheng-Fowler; Fang Cai; Haiqing Fu; Yong Zhu; Brian Orrison; Gideon Foseh; Don G Blair; Stephen H Hughes; John M Coffin; Andrew M Lewis; Keith Peden
Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c-myc.
International journal of biological sciences 2010;6(2):151-62.
2009: Haruhiko Murata; Belete Teferedegne; Andrew M Lewis; Keith W C Peden
A quantitative PCR assay for SV40 neutralization adaptable for high-throughput applications.
Journal of virological methods 2009;162(1-2):236-44.
2009: Li Sheng-Fowler; Andrew M Lewis; Keith W C Peden
Quantitative determination of the infectivity of the proviral DNA of a retrovirus in vitro: Evaluation of methods for DNA inactivation.
Biologicals : journal of the International Association of Biological Standardization 2009;37(4):259-69.
2009: Li Sheng-Fowler; Andrew M Lewis; Keith W C Peden
Issues associated with residual cell-substrate DNA in viral vaccines.
Biologicals : journal of the International Association of Biological Standardization 2009;37(3):190-5.
2008: Haruhiko Murata; Belete Teferedegne; Li Sheng; Andrew M Lewis; Keith W C Peden
Identification of a neutralization epitope in the VP1 capsid protein of SV40.
Virology 2008;381(1):116-22.
2008: Li Sheng; Fang Cai; Yong Zhu; Achintya Pal; Meropi Athanasiou; Brian Orrison; Donald G Blair; Stephen H Hughes; John M Coffin; Andrew M Lewis; Keith W C Peden
Oncogenicity of DNA in vivo: tumor induction with expression plasmids for activated H-ras and c-myc.
Biologicals : journal of the International Association of Biological Standardization 2008;36(3):184-97.
2008: Haruhiko Murata; Keith W C Peden; Andrew M Lewis
Identification of a mutation in the SV40 capsid protein VP1 that influences plaque morphology, vacuolization, and receptor usage.
Virology 2008;370(2):343-51.
2008: Keith W C Peden; Li Sheng; Romelda Omeir; Maureen Yacobucci; Michael Klutch; Majid Laassri; Konstantin Chumakov; Achintya Pal; Haruhiko Murata; Andrew M Lewis
Recovery of strains of the polyomavirus SV40 from rhesus monkey kidney cells dating from the 1950s to the early 1960s.
Virology 2008;370(1):63-76.
2008: Manu Manohar; Brian Orrison; Keith W C Peden; Andrew M Lewis
Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice.
Biologicals : journal of the International Association of Biological Standardization 2008;36(1):65-72.
2006: Achintya Pal; Lev Sirota; Thomas Maudru; Keith W C Peden; Andrew M Lewis
Real-time, quantitative PCR assays for the detection of virus-specific DNA in samples with mixed populations of polyomaviruses.
Journal of virological methods 2006;135(1):32-42.
2001: Andrew M Lewis; P Krause; Keith W C Peden
A defined-risks approach to the regulatory assessment of the use of neoplastic cells as substrates for viral vaccine manufacture.
Developments in biologicals 2001;106():513-35.
2001: Andrew M Lewis
Developing an approach to evaluate the use of neoplastic cells as vaccine substrates.
Developments in biologicals 2001;106():37-42; discussion 42-3.
2001: Keith W C Peden; Andrew M Lewis; Thomas Maudru
Application of quantitative methods for the detection of adventitious agents.
Developments in biologicals 2001;106():333-9.